Behavioral Treatment of Insomnia in Aging
Aging, Insomnia
About this trial
This is an interventional treatment trial for Aging focused on measuring sleep disorders, meditation, cognitive behavior therapy
Eligibility Criteria
Inclusion Criteria: Older than 55 years of age at time of entry Sleep-onset delay, maintenance insomnia, or terminal insomnia Difficulties with sleep for a minimum of 3 nights per week Insomnia duration of at least 6 months Complaint of at least 1 negative effect during waking hours (e.g., fatigue, impaired functioning, mood disturbances) attributed to insomnia Habitual sleep-wake schedule reporting "lights-out" between 9:00 PM and midnight Accessible geographically Exclusion Criteria: Evidence that insomnia is directly related to a medical disorder (e.g., hyperthyroidism) or effects of a medication that affects sleep structure and/or immune functioning Presence of sleep apnea or periodic limb movements during sleep Presence of another sleep disorder (e.g., Advanced or Delay Sleep Phase Syndrome) Regular use of a hypnotic or psychotropic medication (sleeping pills) and/or current psychotherapy or other behavioral therapy that would confound CBT or TCC Current history of a major psychiatric disorder (e.g. current major depression, alcohol or substance dependence, anxiety disorder) Cognitive impairment as suggested by a score lower than 23 on the Mini-Mental State examination Abnormal screening laboratory tests (e.g., abnormal thyroid hormone, elevated TSH, positive screening for HIV or hepatitis C) Smokers will also be excluded because of potential confounding effects on markers of inflammation Body mass index that is greater than 30 kg/m2 as obesity is associated with excessive levels of inflammatory markers Women must be post-menopausal Unable to commit to intervention schedule
Sites / Locations
- Cousins Center for Psychoneuroimmunology, UCLA Neuropsychiatric Institute
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Active Comparator
CBT
TCC
SS